Roche Hopes For Melanoma Therapy Approval
Swiss pharmaceutical giant Roche Holdings recently filed an application with the FDA to review its experimental drug Cobimetinib for the treatment of melanoma, in combination with already marketed drug Zelboraf. The therapy is meant to be used for ...
Forbes - Wed, 17 Dec 2014 10:33

Melanoma 2014: Another Banner Year
Editor's Note: An avalanche of drugs and drug approvals, new combination therapies, and clear improvement in survival rates made 2014 an exciting year in melanoma. Primarily on the basis of Medscape Oncology coverage and input from melanoma experts ...
Medscape - Thu, 18 Dec 2014 09:13

Sometimes overlooked, melanoma can be deadly
While they received support from family and friends and a fundraiser from Fuller's employer, Gusto Distributing, Downs and Fuller say that lack of understanding about melanoma is common. Many people who heard about Downs' diagnosis took the news ...
Great Falls Tribune - Mon, 15 Dec 2014 20:52

Novogen Announces Breakthrough Discovery in the Treatment of Melanoma
The first is that it confirms that TRXE-009 is an important new potential treatment for melanoma, including for the treatment of secondary brain cancers due to melanoma, for which there currently are no effective therapies. The second is that it offers ...
PR Newswire (press release) - Tue, 16 Dec 2014 07:05

Brain cancer candidate touted for melanoma
Medical Marketing and Media - Tue, 16 Dec 2014 13:15

Novogen Ltd. (NVGN) Surged To A 9-Month High On Melanoma Treatment News
RTT News - Wed, 17 Dec 2014 04:22

Amazing Find Leads to Triple-Digit Gain
Wall Street Daily - Thu, 18 Dec 2014 11:30

The Evolving Treatment Landscape in Advanced Melanoma
Metastatic melanoma is associated with a poor prognosis, but recent breakthroughs in tumor biology and immune regulation have led tothe development of agents that could change clinical practice, according to a panel of experts who participated in a ...
OncLive - Thu, 18 Dec 2014 07:56

Year in Review: Progress in Melanoma
After several years of dramatic developments in melanoma therapy, 2014 proved to be a year of incremental growth in understanding the disease process and its clinical management. Melanoma specialists continued to accumulate information about ...
MedPage Today - Wed, 17 Dec 2014 12:48

New Drugs Could Treat BRAF-Inhibitor Resistant Melanoma
Marais and colleagues conducted this study in an attempt to discover an effective second-line treatment for patients with BRAF-mutant melanoma who develop resistance to BRAF inhibition. To do that they designed and synthesized molecules shaped to ...
Cancer Network - Wed, 17 Dec 2014 09:48

New Drugs to Treat Drug-Resistant Melanoma on the Horizon
HCPLive - Thu, 18 Dec 2014 13:56

New Drugs To Treat Drug Resistant Melanoma Discovered by Researchers
Melanoma News Today - Thu, 18 Dec 2014 04:45

Sentinel Lymph Node Biopsy Does Not Up Survival in Melanoma Arising in ...
FRIDAY, Dec. 19, 2014 (HealthDay News) -- For patients with melanoma arising in head and neck subsites (HNM), there is no association between sentinel lymph node biopsy (SLNB) and disease-specific survival (DSS), according to research published in ...
HCPLive - Fri, 19 Dec 2014 14:07

SLNB Doesn't Up Survival in Melanoma Arising in Head, Neck
Doctors Lounge - Fri, 19 Dec 2014 10:00

1  2  3  4  5  6  7  8    ->

We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014